News

“Besides the success with FENO-ARONIA and FENO-CHAGA™, we also achieved a possible raw-material partnership, which could put us in a very strong position on one key raw material. We were also graced with the support of our Board member, Dr. Diane Clayton, who supported us in many customer meetings and liaised with many scientists that […]

Introducing FENO-ARONIA™ 50 OrganicDose matters™. Strength matters. Bioactivity of your supplement matters. That’s why we’re thrilled to announce the launch of FENO-ARONIA™ 50 Organic — a unique, excipient-free, high-strength Aronia extract made from organic aronia berries growing in the pristine soil of Finland. Manufactured with our proprietary extraction and purification technology, it sets a new benchmark for purity, potency, and clean formulation potential. Researches indicate cardio-vascular health benefitsAronia […]

Eevia Health Plc is experiencing a sharp spike in requests for prices and products as ripple effects from the U.S. imposed China tariffs, which now disrupt global nutraceutical supply chains. Several major U.S.-based companies are urgently seeking alternative sources for compendial plant-based ingredients—especially low-concentrate powders—to mitigate the risk of stockouts and margin pressure caused by […]

We are proud to announce our participation at Vitafoods 2025, the leading global nutraceutical trade show, taking place in Barcelona, Spain, 20–22 May 2025. During the event, Eevia will launch a new, innovative health ingredient and support the re-launch of a third ingredient in collaboration with a new partner. Vitafoods is the premier meeting place […]

Eevia Health has published a whitepaper summing a study that compares the bioequivalence between Fenoprolic® and Pycnogenol®, two leading pine bark extracts known for their high levels of oligomeric proanthocyanidins (OPCs). Fenoprolic® is derived from the bark of Arctic pine trees (Pinus sylvestris) sourced from the pristine forests of Finnish Lapland. This region’s pure environment ensures the highest quality raw materials, resulting in a potent […]

Eevia publishes an article on the comparison of bioactivity profiles between Fenoprolic®, Eevia’s pine bark extract, and Pycnogenol®. Eevia extensively studied the bioactivity of Fenoprolic® and Pycnogenol® with the Eurofins BioMAP® Human Primary Cell Phenotypic profiling platform. The article benchmarks Eevia’s extract against the market leader for OPC extracts from pine bark. The study showed […]

To advance the commercial development of Eevia Health, we are thrilled to announce that Erik Eide has joined our team as Commercial Director. It is a new position that will be key to future revenue generation. Erik’s focus is on developing Eevia Health’s position as a trusted supplier of nutraceutical ingredients. He complements the leadership […]

Eevia appoints Breko as a distributor in DACH countries Eevia Health has appointed Breko GmbH out of Bremen as its new distributor in Germany, Austria, Switzerland, and some selected Asian countries. Breko has a long and robust history and offers a range of ingredient products for the food and beverage industry as well as for […]

Clinical Insights into the Therapeutic Potential of Bilberry (Vaccinum myrtillus L.) and its Extracts The scientific review of the clinical benefits that are documented in human clinical trials for bilberry and its extracts is now out and you can read the full report by typing your email below and clicking “Download”. This is a follow-up […]

Meet Eevia team at SSW Polyphenols will play a huge role in supporting human health. Eevia Health extracts some of the most potent polyphenols on this planet from arctic organic plant material. If you are interested in discussing the intriguing prospects of powerful polyphenols, let us meet at Supply Side West at booth # 3541. […]